SOLENO THERAPEUTICS INC (SLNO) Cash flow
Market cap
$1.9B
P/E ratio
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 345,435 | 942,369 | 871,270 | 880,031 | 1 | 1 | 2 | 3 | 3 | 6 | 100 |
| Cash from operations | -4,484,362 | -10,299,330 | -13,497,980 | -6,918,768 | -10 | -17 | -25 | -28 | -21 | -25 | -69 |
| Capital expenditures | -30,683 | -55,777 | -38,680 | -2,569 | -0 | -0 | -0 | -0 | -0 | - | -0 |
| Cash from investing | -30,683 | -1,320,777 | -38,680 | 378,782 | -0 | 1 | -0 | -0 | -0 | - | -226 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | - | - | - | - | 50 |
| Cash from financing | 11 | 9 | 11 | 24 | 18 | 14 | 54 | -0 | 14 | 180 | 213 |
| Free cash flow | - | ||||||||||
| FCF margin (%) | - | - | - | - | - | - | - | - | - |